SEC Form 4 · accession 0000899243-18-006980
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E. Hughes
Officer — See Remarks · Director
Period of report
Mar 7, 2018
Accepted (ET)
Mar 9, 2018 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 7, 2018 | S | 5,000 | $10.00 | D | 157,247 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2Includes 4,876 shares acquired under the employee stock purchase plan purchased in July 2017 and in January 2018.
Remarks
President and Chief Scientific Officer